13F Insight
DOSSIER · 13F Holders · Q3 2026

NASUS PHARMA LTD

10 institutions still hold NASUS PHARMA LTD as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP M7071P109·10 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$8M
visible holders
Holders
10
filers reporting
Concentration
41.48%
BALYASNY ASSET MANAGEMENT L.P. #1
top holder share
AI Holders Summary · Q3 2026

10 institutions reported NASUS PHARMA LTD in Q3 2026. BALYASNY ASSET MANAGEMENT L.P. leads at 41.5% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
BALYASNY ASSET MANAGEMENT L.P.
CIK 0001218710
$3M898K0.00%Q2 202602
Cable Car Capital, LP
CIK 0001699575
$2M616K0.05%Q2 202603
Velan Capital Investment Management LP
CIK 0001848809
$1M359K0.77%Q2 202604
Hudson Bay Capital Management LP
CIK 0001393825
$497K135K0.00%Q3 202605
Bleichroeder LP
CIK 0001781002
$332K90K0.03%Q3 202606
CITADEL ADVISORS LLC
CIK 0001423053
$77K22K0.00%Q2 202607
XTX Topco Ltd
CIK 0001828301
$58K17K0.00%Q2 202608
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
$54K15K0.00%Q3 202609
MORGAN STANLEY
CIK 0000895421
$4K1K0.00%Q3 202610
Caitong International Asset Management Co., Ltd
CIK 0001963355
$1540.00%Q3 2026